OTC •
Healthcare •
Biotechnology •
Quote as of 05/08/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeOTC
Market Capitalization46,168 mln
Float482 mln
Earnings Date02/10/2026
EPS
6.17
Strong
P / E
14.10
Fair value
Piotroski F-Score
8
/ 9
Very strong
Beneish M-Score
-2.46
Borderline
Relative Strength
25
/ 100
Underperforming
Debt / Equity
0.60
Moderate leverage
Business Description
CSL Limited is a global healthcare company founded in 1916 and based in Melbourne, Australia, that develops and delivers medicines and vaccines to patients across more than a dozen countries. Its three main business units cover a broad range of medical needs, including treatments derived from blood plasma, influenza vaccines supplied to governments worldwide, and medicines that address iron deficiency and kidney-related conditions. The company also pursues gene therapies and licenses its scientific innovations to other organizations.
